The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Induction of Androgen Receptor Expression by Phosphatidylinositol 3-Kinase/Akt Downstream Substrate, FOXO3a, and Their Roles in Apoptosis of LNCaP Prostate Cancer Cells
Open accessAbstract
The phosphatidylinositol 3-kinase (PI3K)/Akt pathway plays important roles for prostate cancer cell survival, and the androgen receptor (AR) plays essential roles for prostate cancer cell proliferation. How these two signals cooperate to control cell growth and death, however, remains unclear and debated. Here we provide the first linkage by the identification of Forkhead transcription factor FOXO3a, the PI3K/Akt downstream substrate, as a positive regulator for the induction of AR gene expression. Both Western blot and real time PCR assays demonstrate that FOXO3a can induce AR expression at the protein and mRNA levels, and gel shift and chromatin immunoprecipitation assays further demonstrate that FOXO3a can induce 5' AR promoter activity via binding to the consensus DNA-binding sequence in the AR 5' promoter -1290 to -1297 (5'-TTGTTTCA-3'). Under normal growth conditions, blocking PI3K/Akt signals by LY294002 causes LNCaP cell arrest in G1 phase rather than apoptosis. However, further blocking of AR functions by AR small interfering RNA leads to dramatic LNCaP cell death, suggesting that AR may play important protective roles when the PI3K/Akt signal pathway is blocked by LY294002. Together, our data provide the first model to explain how PI3K/Akt and AR can cooperate to control LNCaP cell growth and death under normal conditions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, both FOXO3a and GSK-3β modulate transcription of androgen receptor (AR); while the former promotes transcriptional activity of AR (49), the latter acts as its inhibitor (50).”
From Anabolic effect of plant brassinosteroid (2011) · cites this paper as [49]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The development of androgen-independent prostate cancer.
Feldman, B. J., & Feldman, D. (2001) · Nature reviews. Cancer · doi:10.1038/35094009 · Cited by 2,326
Androgen Receptor in Prostate Cancer
Heinlein, C. A., & Chang, C. (2004) · Endocrine Reviews · doi:10.1210/er.2002-0032 · Cited by 1,780
Self-citation(2004) · doi:10.1016/s0092-8674(04)00452-0 · Cited by 1,356
Molecular Cloning of Human and Rat Complementary DNA Encoding Androgen Receptors
Chang, C. S., Kokontis, J. M., & Liao, S. (1988) · Science · doi:10.1126/science.3353726 · Cited by 891
Self-citationFuruyama, T., Nakazawa, T., Nakano, I., & Mori, N. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3490629 · Cited by 672
Cell cycle and death control: long live Forkheads
Burgering, B. M. T., & Kops, G. J. P. L. (2002) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(02)02113-8 · Cited by 642
cell cycle and death control: long live Forkheads
Burgering, B. M. T., Medema, R. H., & Kops, G. J. P. L. (2002) · GBM Annual Fall meeting Halle 2002 · doi:10.1240/sav_gbm_2002_h_000075 · Cited by 584
The Roles of Androgen Receptors and Androgen-Binding Proteins in Nongenomic Androgen Actions
Heinlein, C. A., & Chang, C. (2002) · Molecular Endocrinology · doi:10.1210/me.2002-0070 · Cited by 568
Self-citationFuruyama, T., Nakazawa, T., Nakano, I., et al. (2000) · Biochemical Journal · doi:10.1042/bj3490629 · Cited by 505
Wen, Y., Hu, M. C. ‐., Makino, K., Spohn, B., Bartholomeusz, G. A., Yan, D., & Hung, M. (2000) · PubMed · Cited by 461
Flagged first, then by citations
Research works printed but not linked: 7
- Lin, 1999, Cancer Res., 59, 2891
- Altuwaijri, 2003, Cancer Res., 63, 7106
- Wen, 2000, Cancer Res., 60, 6841
- Truica, 2000, Cancer Res., 60, 4709
- Malik, 2002, Clin. Cancer Res., 8, 1168
- Zegarra-Moro, 2002, Cancer Res., 62, 1008
- Mizokami, 1994, Mol. Endocrinol., 8, 77
Cited by
Sorted by citations
Items 101–131 of 131
Xu, K., Zhang, K., Ma, J., Yang, Q., Yang, G., Zong, T., Wang, G., Yan, B., Shengxia, J., Chen, C., et al. (2023) · Translational Oncology · doi:10.1016/j.tranon.2023.101628 · Cited by 15
Self-citationSGEF is overexpressed in prostate cancer and contributes to prostate cancer progression
Wang, H., Wu, R., Lan, Y., Wu, F., Li, S., Yali, Z., Li, H., Luo, G., WANG, J., & Zhou, J. (2012) · Oncology Reports · doi:10.3892/or.2012.1917 · Cited by 13
Kyriakopoulos, C. E., Heath, E. I., Eickhoff, J. C., Kolesar, J., Yayehyirad, M., Moll, T., Wilding, G., & Liu, G. (2016) · Investigational New Drugs · doi:10.1007/s10637-016-0334-y · Cited by 12
Toll-like receptor 4-mediated signaling participates in apoptosis of hippocampal neurons.
He, Y., Zhou, A., & Jiang, W. (2013) · PubMed Central · doi:10.3969/j.issn.1673-5374.2013.29.006 · Cited by 12
Park, J. E., Shin, W.-C., Lee, H., Yoon, D., Sim, D. Y., Ahn, C., Park, S., Shim, B. S., Park, S. J., Kim, K. S., et al. (2022) · Phytotherapy Research · doi:10.1002/ptr.7626 · Cited by 10
Dudkowska, M., Jaworski, T., Grzelakowska-Sztabert, B., & Manteuffel-Cymborowska, M. (2007) · Acta Biochimica Polonica · doi:10.18388/abp.2007_3245 · Cited by 7
Kaaks, R. (2011) · Oncology Reports · doi:10.3892/or.2011.1359 · Cited by 7
Tahsin, S., Sane, N. S., Cernyar, B., Jiang, L., Zohar, Y., Lee, B. R., & Miranti, C. K. (2024) · Oncogene · doi:10.1038/s41388-024-03064-7 · Cited by 5
FOXO3a: A Potential Target in Prostate Cancer.
Shukla, S. (2014) · PubMed · Cited by 5
Grupp, K., Uzunoglu, F. G., Melling, N., Hofmann, B. T., Gammal, A. T. E., Grotelüschen, R., Heumann, A., Bellon, E., Reeh, M., Wolters‐Eisfeld, G., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-35459-4 · Cited by 4
Xie, X., Manai, M., Rampa, D. R., Fuson, J. A., Nakasone, E. S., Pearson, T., Kuntal, B. S., Tripathy, D., Ueno, N. T., & Lee, J. (2024) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-23-0386 · Cited by 4
Hu, J., Hong, Y., Xie, X., Yuan, Y., Liu, W., & Fu, B. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e27568 · Cited by 3
Androgen-Sensitized Apoptosis of HPr-1AR Human Prostate Epithelial Cells
Chen, C., Dienhart, J. A., & Bolton, E. C. (2016) · PLoS ONE · doi:10.1371/journal.pone.0156145 · Cited by 2
Zhang, J., Xiang, J.-Q., Zhang, Y., Chen, Y., Zhou, X.-Y., Liu, Y., & Li, S. (2007) · International Journal of Molecular Sciences · doi:10.3390/i8020156 · Cited by 2
Self-citationOxidative Stress and Castration-Resistant Prostate Cancer
Shiota, M. (2018) · Springer eBooks · doi:10.1007/978-981-10-7013-6_21 · Cited by 2
Disruptors of Androgen Action and Synthesis
Sanderson, J. T. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-801139-3.00004-1 · Cited by 1
Walter, P. (2006) · Univ. Duesseldorf: Duesseldorfer Dokumenten- und Publikationsserver
Prostate Cancer Progression to Androgen Independent Disease: The Role of the PI3K/AKT Pathway
Jacqueline, R., Huang, Y., Persad, A. R. L., & Pers, S. (2013) · InTech eBooks · doi:10.5772/53483
Androgen receptor-mediated growth suppression and apoptosis of human prostate epithelial cells
Chen, C. (2016) · Illinois Digital Environment for Access to Learning and Scholarship (University of Illinois at Urbana-Champaign)
Epigenetic Study of Plasma Circulating DNA in Prostate Cancer
Kwan, A. (2015) · TSpace (University of Toronto)
Leighton, X., Pollard, H. B., & Srivastava, M. (2018) · InTech eBooks · doi:10.5772/intechopen.75165
Investigating the role of amino acid transporter LAT3/SLC43A1 in prostate cancer
Zhang, K. (2019) · The Sydney eScholarship Repository (The University of Sydney)
Disruptors of Androgen Action and Synthesis
Sanderson, J. T. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-821985-0.00021-9
Huang, W., Havel, J. J., Zhau, H. E., Qian, W. P., Lue, H.-W., Chu, C.-Y., Nomura, T., & Chung, L. W. K. (2023) · doi:10.1158/1078-0432.c.6517272
Huang, W., Havel, J. J., Zhau, H. E., Qian, W. P., Lue, H.-W., Chu, C.-Y., Nomura, T., & Chung, L. W. K. (2023) · doi:10.1158/1078-0432.c.6517272.v1
Androgen Receptor Signaling: A Central and Evolving Theme in Prostate Cancer Treatment
Banerjee, P. P., & Srivastava, S. K. (2023) · Springer eBooks · doi:10.1007/978-981-99-2196-6_24-1
Androgen Receptor Signaling: A Central and Evolving Theme in Prostate Cancer Treatment
Banerjee, P. P., & Srivastava, S. K. (2024) · Springer eBooks · doi:10.1007/978-981-99-6263-1_24 · Cited by 1
Zhu, Y., Long, M., Shi, W., He, T., Xie, F., Qian, A., Liu, Y., Hu, T., & Tang, S. (2025) · Scientific Reports · doi:10.1038/s41598-025-23449-2
Characterization of a tumour suppressor function of RanBPM
Atabakhsh, E. (2012) · Scholarship@Western (Western University)
Novel Strategies for Neurovascular Longevity During Aging
Maiese, K., Chong, Z. Z., Hou, J., & Shang, Y. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-602-3_9
Metadata
- Authors
- Yang, L., Xie, S., Jamaluddin, M. S., Altuwaijri, S., Ni, J., Kim, E., Chen, Y.-T., Hu, Y.-C., Wang, L., Chuang, K.-H., Wu, C.-T., & Chang, C.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- University of Rochester Medicine (US)
- Baylor College of Medicine (US)
- Chang Gung University (TW)
- Corresponding author
- Chang, Chawnshang
- ORCID
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2005-09
- Volume
- 280
- Issue
- 39
- Pages
- 33558-33565
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2158889317
- Cited by
- 131
- References
- 42
- Citations by year
- 2025: 1 · 2024: 5 · 2023: 5 · 2022: 3 · 2021: 3 · 2020: 4 · 2019: 5 · 2018: 6 · 2017: 5 · 2016: 4 · 2015: 9 · 2014: 6 · 2013: 5 · 2012: 8
- FWCI
- 3.64
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r29ca071870-05)
- National Cancer Institute (CA55639, CA-71870)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK 60948, R01DK067686, DK67686, R01DK060948)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › FOXO transcription factor regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Prostate Cancer Treatment and Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Keywords
- androgen receptor, FOXO3, PI3K/Akt signaling, prostate cancer, apoptosis, LNCaP cells, transcriptional regulation, G1 cell cycle arrest, LY294002
- MeSH terms
- Forkhead Box Protein O3, Phosphoinositide-3 Kinase Inhibitors, Chromones, Enzyme Inhibitors, Humans, Male, Models, Biological, Morpholines, Promoter Regions, Genetic, Prostatic Neoplasms, Receptors, Androgen, RNA, Messenger, Gene Expression Regulation, Neoplastic, Apoptosis, Prostate-Specific Antigen, Phosphatidylinositol 3-Kinases, RNA, Small Interfering, Cell Line, Tumor, Chromatin Immunoprecipitation, Forkhead Transcription Factors, Androgen Receptor Antagonists
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
